Tyrosine for Methamphetamine Dependence - 1

National Institutes of Health (NIH)

Status and phase: Completed; Phase 2

Conditions: Amphetamine-Related Disorders

Treatments: Behavioral: Tyrosine

Study type: Interventional

Funder types: NIH

Identifiers

NCT00000322

R01-10739-1

NIDA-10739-1

Details and patient eligibility

About

The purpose of this study is to evaluate efficacy of tyrosine as a treatment for methamphetamine dependence in an outpatient treatment setting providing group psychosocial interventions. Examine effect of tyrosine on abstinence, retention in treatment, and craving."

Full description

Evaluate efficacy of tyrosine as a treatment for methamphetamine dependence in an outpatient treatment setting providing group psychosocial interventions. Examine effect of tyrosine on abstinence, retention in treatment and craving.

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

18-65 years of age. Able to provide informed consent. Desire to reduce/eliminate methamphetamine use. Used within the past two weeks. Meet DSM criteria for methamphetamine dependence.

Exclusion criteria

No dependence (within the past 12 months) for other durgs except nicotine. No history or family history of tyrosine intolerance.